Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Annual fiscal-year EPS history; the page headline uses the current trailing EPS value. Historical series through 2025-12-31.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-12.74
EARNINGS PER SHARE (EPS) AVG 3Y
-17.52
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MBody AI Ltd.
Market Cap
$3.21M
Earnings Per Share (EPS)
N/A
TTM Avg
-12.74
3Y Avg
-17.52
5Y Avg
N/A
Market Cap
$3.21M
Earnings Per Share (EPS)
N/A
TTM Avg
-1108.98
3Y Avg
-1045.55
5Y Avg
-1171.01
Market Cap
$3.04M
Earnings Per Share (EPS)
-22.20
TTM Avg
-27.40
3Y Avg
-44.30
5Y Avg
-249.07
Market Cap
$3.32M
Earnings Per Share (EPS)
-11.70
TTM Avg
-48.19
3Y Avg
-238.41
5Y Avg
-340.02
Market Cap
$3.33M
Earnings Per Share (EPS)
-6.76
TTM Avg
-8.05
3Y Avg
-9.85
5Y Avg
-9.67
Market Cap
$2.95M
Earnings Per Share (EPS)
-1.43
TTM Avg
-2.52
3Y Avg
-2.09
5Y Avg
-1.32
Market Cap
$3.40M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.99
3Y Avg
-3.92
5Y Avg
-2.83
Market Cap
$3.42M
Earnings Per Share (EPS)
-4.90
TTM Avg
-7.69
3Y Avg
-8.41
5Y Avg
-8.41
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBody AI Ltd. (MBAI) | $3.21M | N/A | -12.74 | -17.52 | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.21M | N/A | -1108.98 | -1045.55 | -1171.01 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | -22.20 | -27.40 | -44.30 | -249.07 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.32M | -11.70 | -48.19 | -238.41 | -340.02 |
| IceCure Medical Ltd (ICCM)vs › | $3.33M | -6.76 | -8.05 | -9.85 | -9.67 |
| Eocene Ltd. (EOCN)vs › | $3.44M | N/A | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.95M | -1.43 | -2.52 | -2.09 | -1.32 |
| Evogene Ltd. (EVGN)vs › | $3.40M | -0.91 | -1.99 | -3.92 | -2.83 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | -4.90 | -7.69 | -8.41 | -8.41 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -0.45 | -1.48 | -5.05 | -8.12 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-0.02
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 4.62 |
| 2024-12-31 | -30.10 |
| 2023-12-31 | -21.00 |
| 2022-12-31 | -23.59 |
| 2021-12-31 | -21.21 |
